CClinicalTrials.gg
Sign In
Status unknownNCT04485715Updated Jul 24, 2020

Application of AI in Polypectomy

An interventional study of AI system in Colonic Polyp, sponsored by Yanqing Li. Status unknown at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-07-24.

Sponsored by Yanqing Li · Not applicable, Interventional, and Other

The sponsor has not verified this record recently (last verified Jul 2020), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The aim of this study was to assess the performance of AI system in polypectomy

02

Conditions studied

  • Colonic Polyp

Browse trials for

03

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • to undergo colorectal polypectomy;
  • agree to give written informed consent

Exclusion criteria

Exclusion Criteria:

  • patients with the contraindications to colorectal polypectomy;
  • patients with a history of inflammatory bowel disease (IBD), CRC, colorectal surgery;
  • patients with high suspicion of polyposis syndromes, IBD and typical advanced CRC;
  • patients refused to participate in the trial;
  • the procedure cannot be completed due to stenosis, obstruction, huge occupying lesions, or solid stool;
  • the procedure have to be terminated due to complications of anaesthesia.
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
1,000 participants (estimated)

Study arms

  • Experimental
    AI-aided group

    Other: AI system

  • No intervention
    control group

Interventions

  • OtherAI system

    The real-time assistance of AI system

05

What researchers measure

Primary outcomes

  1. polypectomy time

    the time for detection in polypectomy

    Time frame: 12 months

06

Study locations

1 of 1 sites recruiting
  • Department of Gastroenterology, Qilu Hospital, Shandong University
    Jinan, Shandong, China
    Recruiting
07

Registry details

Key details

Study ID
NCT04485715
Lead sponsor
Yanqing Li
Responsible party
Yanqing Li (gastroenterology professor of Qilu Hospital, Shandong University) — Sponsor-investigator
First posted
Jul 24, 2020
Start date
Jul 21, 2020 (estimated)
Primary completion
Jul 21, 2021 (estimated)
Completion
Sep 21, 2021 (estimated)
Last update
Jul 24, 2020

Study contacts

Yanqing Li, PhD, MD
Contact
liyanqing@sdu.edu.cn
86-531-82166095

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Colonic Polyps→

Other studies from this sponsor

Yanqing Li

Start the discussion